Crossmark

Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients

Published Online: 2022-11-22

Authors

Zhalka, Fidaa El http://orcid.org/0000-0002-8491-5085
Moisseiev, Elad

Rubowitz, Alexander
License Information

Text and Data Mining valid from 2022-11-22

Version of Record valid from 2022-11-22
More Information

Article History

Received: 8 October 2022

Accepted: 9 November 2022

First Online: 22 November 2022

Declarations

:

: It is a retrospective study approved by the Institutional Review Board of Meir Medical Center.

: Not relevant.

: There is no Compteting interest for any of the authors.

Document is current